NCT00853255 arm group c4ca4238a0b923820dcc509a6f75849b [clinicaltrials_resource:NCT00853255/arm-group/c4ca4238a0b923820dcc509a6f75849b]
NCT00853255 arm group c4ca4238a0b923820dcc509a6f75849b [clinicaltrials_resource:NCT00853255/arm-group/c4ca4238a0b923820dcc509a6f75849b]
Bio2RDF identifier
NCT00853255/arm-group/c4ca4238a0b923820dcc509a6f75849b
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... ca4238a0b923820dcc509a6f75849b
description [clinicaltrials_vocabulary:description]
Participants will receive 0.5 ...... vice (0.25 mL in each nostril)
identifier
clinicaltrials_resource:NCT00853255/arm-group/c4ca4238a0b923820dcc509a6f75849b
title
NCT00853255 arm group c4ca4238a0b923820dcc509a6f75849b
@en
type
label
NCT00853255 arm group c4ca4238 ...... a4238a0b923820dcc509a6f75849b]
@en